Boundless Bio, Inc.
USD1.44
+0.01 (+0.70%)
CEO
Zachary Hornby
IPO Date
2016-07-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.44
Prev. Close
$1.43
Day Low
$1.43
Day High
$1.45
52W Low
$0.96
52W High
$1.68
Market Cap
$0.03B
Volume
0.13M
| 230,000 |
| $1.26 |
| 26 Jan 2026 | Doebele Robert | Chief Medical Officer | A-Award | Acquired | 230,000 | $1.26 |
| 26 Jan 2026 | Hornby Zachary | director, officer: President & CEO | A-Award | Acquired | 600,000 | $1.26 |
| 26 Jan 2026 | HINKLE DAVID A | See Remarks | A-Award | Acquired | 140,000 | $1.26 |
| 23 Jun 2025 | Brennan Christine | director | A-Award | Acquired | 16,000 | $1.03 |
| 23 Jun 2025 | Christensen James | director | A-Award | Acquired | 16,000 | $1.03 |
| 23 Jun 2025 | Lew Jennifer | director | A-Award | Acquired | 16,000 | $1.03 |
| 23 Jun 2025 | Lim Jonathan E | director | A-Award | Acquired | 24,000 | $1.03 |
| 23 Jun 2025 | Burow Kristina | director, 10 percent owner: | A-Award | Acquired | 16,000 | $1.03 |